Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Betul Bozkurt Bulakcı"'
Autor:
Betul Bozkurt Bulakcı, Aynur Daglar Aday, Basak Gurtekin, Akif Selim Yavuz, Sukru Ozturk, Kivanc Cefle, Ayse Palanduz, Sukru Palanduz
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 38:668-674
The introduction of tyrosine kinase inhibitors (TKI) has resulted in a significant improvement in the treatment of CML patients. However, some CML patients are resistant to imatinib therapy, the initial TKI therapy in the CML. Therefore, it is import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d22dd68a59fbdafd08f971e2c4d7202d
https://doi.org/10.1007/s12288-022-01532-2
https://doi.org/10.1007/s12288-022-01532-2
